Brevinin 2R
General Information
DCTPep ID DCTPep03812
Peptide Name Brevinin 2R
Sequence KLKNFAKGVAQSLLNKASCKLSGQC
Sequence Length 25
PubChem CID Not available
Origin Animalia
Type Native peptide
Classification
Cancer therapy related peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C114H198N34O33S2
Absent amino acids DEHIMPRTWY
Theoretical pI 9.90
Acidic residues 0
Basic residues 5
Polar residues 9
Molecular weight (Average) 2637.15
Molecular weight (Monoisotopic) 2635.43
Common amino acids K
Net charge 5
Instability index (II) 27.08
Aliphatic index 86.00
Grand average of hydropathicity (GRAVY) -0.164
Half Life
1.3 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
3 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 125
Abs 0.1% (=1 g/l) 0.047, assuming all pairs of Cys residues form cystines
Ext. coefficient 0
Abs 0.1% (=1 g/l) 0.000, assuming all Cys residues are reduced
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 18494941
Title Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway
Doi Not available
Year 2008
Literature 2
Pubmed ID 30811391
Title Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L major: In vitro mechanism of actions and in vivo treatment potentials
Doi Not available
Year 2019
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 12878